Product image of Glycopyrronium Bromide Novumgen (Glycopyrronium Bromide) supplied by GNH India

Glycopyrronium Bromide Novumgen

Active Ingredient:
Glycopyrronium Bromide
Origin:
EU

Glycopyrronium Bromide Novumgen (Glycopyrronium Bromide)

Glycopyrronium Bromide Novumgen is a prescription medication containing the anticholinergic agent glycopyrronium bromide. It is supplied in an injectable form for intramuscular or intravenous administration, with dosage strengths that vary according to clinical need. The product is marketed in the European Union and belongs to the antispasmodic and pre‑operative secretions‑reducer therapeutic class. It works by competitively blocking muscarinic acetylcholine receptors, thereby decreasing parasympathetic activity in patients.

Manufacturer / TM Owner

Novumgen Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glycopyrronium Bromide Novumgen is used in several peri‑operative and dermatologic settings where reduction of secretions or sweating is desired.

  • Preoperative reduction of salivary, bronchial, and other airway secretions to facilitate anesthesia.
  • Adjunctive therapy during general anesthesia to minimize intra‑operative secretions.
  • Management of primary hyperhidrosis affecting the axillae, palms, or soles.
  • Treatment of excessive oral secretions in patients with neurological disorders.
  • Use as an antispasmodic in gastrointestinal procedures where decreased motility is beneficial.

Side Effects

The safety profile of Glycopyrronium Bromide Novumgen reflects its anticholinergic activity, with side effects ranging from mild to potentially serious.

Common

  • Dry mouth.
  • Reduced sweating leading to heat intolerance.
  • Blurred vision.
  • Constipation.
  • Urinary retention.
  • Tachycardia.

Serious

  • Severe allergic reaction (anaphylaxis).
  • Acute angle‑closure glaucoma.
  • Cardiac arrhythmias.
  • Persistent hyperthermia.

Precautions & Warnings

When prescribing Glycopyrronium Bromide Novumgen, clinicians should evaluate several precautionary factors to ensure safe use.

  • Assess for known hypersensitivity to glycopyrronium or related anticholinergics.
  • Use cautiously in patients with glaucoma, especially narrow‑angle type.
  • Monitor cardiac function in individuals with pre‑existing arrhythmias or heart block.
  • Avoid in patients with uncontrolled urinary retention or severe gastrointestinal obstruction.
  • Consider dose adjustment in the elderly or those with renal impairment.
  • Evaluate pregnancy status; safety data are limited.

Avoid Interactions

Glycopyrronium Bromide Novumgen can modify the effects of other medications, requiring attention to potential drug‑drug interactions.

Avoid

  • Concurrent use with other anticholinergic agents (e.g., atropine, scopolamine) may intensify anticholinergic toxicity.
  • Combination with reversible cholinesterase inhibitors (e.g., neostigmine) can reduce therapeutic effect.

Use with caution

  • Beta‑blockers or other agents that affect heart rate may increase risk of bradycardia or tachycardia.
  • Anesthetic agents that depress respiratory drive (e.g., opioids) may compound secretory reduction.
  • Drugs that prolong QT interval should be monitored when given together.
  • Herbal supplements with anticholinergic properties (e.g., belladonna) may add to side effects.

Frequently Asked Questions

Glycopyrronium Bromide Novumgen competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic activity and thereby decreasing secretions and smooth‑muscle tone.

It is commonly administered before general anesthesia to reduce salivary, bronchial, and airway secretions, helping to maintain a clear airway during surgery.

Yes, the drug is indicated for the management of primary hyperhidrosis, especially in areas such as the axillae, palms, or soles.

The product is supplied for intramuscular (IM) and intravenous (IV) injection.

No, it is a prescription‑only medication (Rx‑only) in the European Union.

Common adverse effects include dry mouth, reduced sweating, blurred vision, constipation, urinary retention, and a mild increase in heart rate.

Serious reactions such as anaphylaxis, acute angle‑closure glaucoma, cardiac arrhythmias, or unexplained high fever should be treated as emergencies.

Patients with narrow‑angle glaucoma should use Glycopyrronium Bromide Novumgen cautiously, as anticholinergic activity can increase intra‑ocular pressure.

Concurrent use with reversible cholinesterase inhibitors (e.g., neostigmine) may diminish the intended anticholinergic effect of Glycopyrronium.

Pregnancy safety data are limited; the product is classified as pregnancy category unknown, so it should be used only if the potential benefit justifies the potential risk.

Store the injectable solution in a cool, dry place, protected from light, and keep it out of reach of children.

Elderly patients may be more sensitive to anticholinergic effects, so clinicians often consider lower initial doses and close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glycopyrronium Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT